Alva Review-Courier -

Articles written by Lauran Neergaard

Sorted by date  Results 1 - 25 of 116



Rare 'breakthrough' COVID cases are causing alarm, confusion

Reports of athletes, lawmakers and others getting the coronavirus despite vaccination may sound alarming but top health experts point to overwhelming evidence that the shots are doing exactly what they are supposed to: dramatically reducing severe...

 

Pfizer COVID-19 shot expanded to US children as young as 12

U.S. regulators on Monday expanded the use of Pfizer's COVID-19 vaccine to children as young as 12, offering a way to protect the nation's adolescents before they head back to school in the fall and paving the way for them to return to more normal...

 

US health panel urges restarting J&J COVID-19 vaccinations

U.S. health advisers on Friday urged resuming COVID-19 vaccinations with Johnson & Johnson's single-dose shot, saying its benefits outweigh a rare risk of blood clots — in line with Europe's rollout. Federal health officials uncovered 15 vaccine...

 

US advisers endorse single-shot COVID-19 vaccine from J&J

WASHINGTON (AP) — U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic. The Food and Drug Administration is expected to...

 

Drug executives: Big jump in vaccine supply is coming soon

WASHINGTON (AP) — COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist they will be able to provide enough for most Americans to get inoculated by summer....

 

FDA says single-dose shot from J&J prevents severe COVID

WASHINGTON (AP) — Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to...

 

What's safe after COVID-19 vaccination? Don't shed masks yet

You're fully vaccinated against the coronavirus — now what? Don't expect to shed your mask and get back to normal activities right away. That's going to be a disappointment, if not a shock, to many people. In Miami, 81-year-old Noemi Caraballo got...

 

Study finds COVID-19 vaccine may reduce virus transmission

AstraZeneca's COVID-19 vaccine shows a hint that it may reduce transmission of the virus and offers strong protection for three months on just a single dose, researchers said Wednesday in an encouraging turn in the campaign to suppress the outbreak....

 

'Simple is beautiful': One-shot vaccine proves effective

The first one-shot COVID-19 vaccine provides good protection against the illness, Johnson & Johnson reported in a key study released Friday, offering the world a potentially important new tool as it races to stay ahead of the rapidly mutating virus....

 

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day. Much-needed doses are set to arrive Monday...

 

US vaccinations ramp up as 2nd COVID-19 shot nears

WASHINGTON (AP) — Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination drive Tuesday, while a second vaccine moved to the cusp of government authorization. A day...

 

US panel endorses widespread use of Pfizer COVID-19 vaccine

WASHINGTON (AP) — A U.S. government advisory panel endorsed widespread use of Pfizer's coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to...

 

Pfizer, BioNTech seek emergency use of COVID-19 shots in US

Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a...

 

AP FACT CHECK: Trump distorts on vaccine, state distribution

WASHINGTON (AP) — President Donald Trump on Friday wrongly claimed full credit for Pfizer Inc.'s announcement that its COVID-19 vaccine was robustly successful and suggested without evidence that a separate state review will cause a protracted...

 

Single-dose vaccine tested as US experts say no corners cut

WASHINGTON (AP) — A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the...

 

US experts vow 'no cutting corners' as vaccine tests expand

WASHINGTON (AP) — A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the...

 

AstraZeneca COVID-19 vaccine study paused after one illness

Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot. In a statement issued Tuesday evening, the...

 

Vaccine by Nov. 3? Halted study explains just how unlikely

WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be "no compromises" on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress...

 

Study hints, can't prove, survivor plasma fights COVID-19

Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it's not proof and some experts worry if, amid clamor for the treatment, they'll ever get a clear answer. More than 64,000...

 

Chinese executives get 'pre-test' injections in vaccine race

BEIJING (AP) — In the global race to make a coronavirus vaccine, a state-owned Chinese company is boasting that its employees, including top executives, received experimental shots even before the government approved testing in people. "Giving a he...

 

Summer may decide fate of leading shots in vaccine race

People on six continents already are getting jabs in the arm as the race for a COVID-19 vaccine enters a defining summer, with even bigger studies poised to prove if any shot really works -- and maybe offer a reality check. Already British and...

 

AP-NORC poll: Half of Americans would get a COVID-19 vaccine

Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, a number that's surprisingly low considering the effort going into the global race for a vaccine. But more people might...

 

US begins 'warp speed' vaccine push as studies ramp up

WASHINGTON (AP) — President Donald Trump vowed to use "every plane, truck and soldier" to distribute COVID-19 vaccines he hopes will be ready by year's end — even as the country's top scientists gear up for a master experiment to rapidly tell if...

 

Coronavirus survivor: 'In my blood, there may be answers'

NEW YORK (AP) — Tiffany Pinckney remembers the fear when COVID-19 stole her breath. So when she recovered, the New York City mother became one of the country's first survivors to donate her blood to help treat other seriously ill patients. "It is...

 

Straight-talking Fauci explains outbreak to a worried nation

WASHINGTON (AP) — If Dr. Anthony Fauci says it, you'd be smart to listen. As the coronavirus has upended daily life across the globe, Fauci has become the trusted voice in separating fact and fiction. The fear and confusion of outbreaks aren't new...

 

Page Down

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021

Rendered 08/04/2021 02:50